These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 5050533

  • 21. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
    Derouin F.
    Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
    [Abstract] [Full Text] [Related]

  • 22. [Preliminary application of PCR to curative effect assessment of chemotherapy against experimental acute infection of Toxoplasma gondii in mice].
    Xiang X, Ke OY, Zhang Z.
    Hunan Yi Ke Da Xue Xue Bao; 1997 Jun; 22(1):5-7. PubMed ID: 9868016
    [Abstract] [Full Text] [Related]

  • 23. The effect of sulfomethoxypyrazine-pyrimethamine therapy on the fine structure of Toxoplasma gondii-cysts in the brain of Mastomys natalensis. Scanning and transmission electron microscopical investigations.
    Matuschka FR.
    Zentralbl Bakteriol Orig A; 1977 Jul; 238(3):419-29. PubMed ID: 910581
    [Abstract] [Full Text] [Related]

  • 24. Considerations on some cases of repeated abortions probabily due to Toxoplasma gondii (author's transl).
    Carollo F, Spanó C, Dardanoni L.
    Acta Eur Fertil; 1972 Mar; 3(1):5-18. PubMed ID: 4679561
    [No Abstract] [Full Text] [Related]

  • 25. [On the effect of SDDS in combination with pyrimethamine or sulfamonomethoxine on cysts of Toxoplasma gondii in NMRI mice (author's transl)].
    Werner H, Catár G.
    Tropenmed Parasitol; 1974 Sep; 25(3):313-7. PubMed ID: 4432280
    [No Abstract] [Full Text] [Related]

  • 26. Effect of killed toxoplasma and sulfamonomethoxine on experimental toxoplasmosis in mice.
    Morita C, Izawa H, Soekawa M.
    Zentralbl Veterinarmed B; 1971 Feb 01; 18(1):15-20. PubMed ID: 5089817
    [No Abstract] [Full Text] [Related]

  • 27. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
    Rodríguez-Díaz JC, Martínez-Grueiro MM, Martínez-Fernández AR.
    Enferm Infecc Microbiol Clin; 1993 Dec 01; 11(10):543-6. PubMed ID: 8142504
    [Abstract] [Full Text] [Related]

  • 28. Chemotherapy and chemoprophylaxis of experimental toxoplasmosis.
    Gill HS, Prakash O.
    Indian J Med Res; 1972 Jul 01; 60(7):1022-7. PubMed ID: 4661450
    [No Abstract] [Full Text] [Related]

  • 29. Chemotherapy in experimental toxoplasmosis: comparison of the efficacy of trimethoprim-sulfur and pyrimethamine-sulfur combinations.
    Seah SK.
    J Trop Med Hyg; 1975 Jul 01; 78(7):150-3. PubMed ID: 1177347
    [Abstract] [Full Text] [Related]

  • 30. Phenylalanine derivatives active against Toxoplasma gondii brain cysts in mice.
    Sarciron ME, Walchshofer N, Paris J, Petavy AF, Peyron F.
    Parasite; 1998 Dec 01; 5(4):359-64. PubMed ID: 9879558
    [Abstract] [Full Text] [Related]

  • 31. Effects of robenidine and some other drugs on mice experimentally infected with toxoplasma.
    Ito S, Tsunoda K, Nishikawa H.
    Natl Inst Anim Health Q (Tokyo); 1974 Dec 01; 14(3):129-36. PubMed ID: 4437645
    [No Abstract] [Full Text] [Related]

  • 32. Zidovudine antagonizes the action of pyrimethamine in experimental infection with Toxoplasma gondii.
    Israelski DM, Tom C, Remington JS.
    Antimicrob Agents Chemother; 1989 Jan 01; 33(1):30-4. PubMed ID: 2712547
    [Abstract] [Full Text] [Related]

  • 33. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
    Barbosa BF, Gomes AO, Ferro EA, Napolitano DR, Mineo JR, Silva NM.
    Vet Parasitol; 2012 Jun 08; 187(1-2):44-52. PubMed ID: 22281151
    [Abstract] [Full Text] [Related]

  • 34. Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in mice.
    Chang HR, Rudareanu FC, Pechère JC.
    J Antimicrob Chemother; 1988 Sep 08; 22(3):359-61. PubMed ID: 2972671
    [Abstract] [Full Text] [Related]

  • 35. Chemotherapy of experimental toxoplasmosis with special reference to robenidine.
    Bakhtari SK, Jíra J.
    Folia Parasitol (Praha); 1988 Sep 08; 35(3):193-8. PubMed ID: 2974008
    [Abstract] [Full Text] [Related]

  • 36. Activity of roxithromycin against Toxoplasma gondii in murine models.
    Chang HR, Pechère JC.
    J Antimicrob Chemother; 1987 Nov 08; 20 Suppl B():69-74. PubMed ID: 3429388
    [Abstract] [Full Text] [Related]

  • 37. [Criteria for the selection of sulfonamides for the treatment of rodent malaria (Plasmodium vinckei)].
    Heischkeil R.
    Z Tropenmed Parasitol; 1972 Jun 08; 23(2):128-43. PubMed ID: 5050535
    [No Abstract] [Full Text] [Related]

  • 38. A pilot study on the efficacy of epiroprim against developmental stages of Toxoplasma gondii and Pneumocystis carinii in animal models.
    Mehlhorn H, Dankert W, Hartman PG, Then RL.
    Parasitol Res; 1995 Jun 08; 81(4):296-301. PubMed ID: 7624286
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of SDDS (2-'sulfamonyl-4,4'-diamino diphenylsulphone) on experimental infection with Toxoplasma gondii in rabbits.
    Kumar PS, Kumar R, Mohapatra LN.
    Indian J Med Res; 1978 Jun 08; 67():908-17. PubMed ID: 721183
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.